GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

D Wang, EA Day, LK Townsend, D Djordjevic… - Nature Reviews …, 2021 - nature.com
Abstract Growth differentiation factor 15 (GDF15) is a member of the TGFβ superfamily
whose expression is increased in response to cellular stress and disease as well as by …

Ischemic heart disease pathophysiology paradigms overview: from plaque activation to microvascular dysfunction

P Severino, A D'Amato, M Pucci, F Infusino… - International journal of …, 2020 - mdpi.com
Ischemic heart disease still represents a large burden on individuals and health care
resources worldwide. By conventions, it is equated with atherosclerotic plaque due to flow …

Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy

AJ Marian, E Braunwald - Circulation research, 2017 - Am Heart Assoc
Hypertrophic cardiomyopathy (HCM) is a genetic disorder that is characterized by left
ventricular hypertrophy unexplained by secondary causes and a nondilated left ventricle …

Genome-wide association studies of cardiovascular disease

R Walsh, SJ Jurgens, J Erdmann… - Physiological …, 2023 - journals.physiology.org
Genome-wide association studies (GWAS) aim to identify common genetic variants that are
associated with traits and diseases. Since 2005, more than 5,000 GWAS have been …

A contraction stress model of hypertrophic cardiomyopathy due to sarcomere mutations

R Cohn, K Thakar, A Lowe, FA Ladha, AM Pettinato… - Stem cell reports, 2019 - cell.com
Thick-filament sarcomere mutations are a common cause of hypertrophic cardiomyopathy
(HCM), a disorder of heart muscle thickening associated with sudden cardiac death and …

Muscle LIM protein force-sensing mediates sarcomeric biomechanical signaling in human familial hypertrophic cardiomyopathy

M Riaz, J Park, LR Sewanan, Y Ren, J Schwan… - Circulation, 2022 - Am Heart Assoc
Background: Familial hypertrophic cardiomyopathy (HCM) is the most common inherited
cardiac disease and is typically caused by mutations in genes encoding sarcomeric proteins …

Stress echo 2030: the novel ABCDE-(FGLPR) protocol to define the future of imaging

E Picano, Q Ciampi, L Cortigiani… - Journal of clinical …, 2021 - mdpi.com
With stress echo (SE) 2020 study, a new standard of practice in stress imaging was
developed and disseminated: the ABCDE protocol for functional testing within and beyond …

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers

A Lyon, R Ariga, A Mincholé, M Mahmod… - Frontiers in …, 2018 - frontiersin.org
Aims: Ventricular arrhythmia triggers sudden cardiac death (SCD) in hypertrophic
cardiomyopathy (HCM), yet electrophysiological biomarkers are not used for risk …

Metabolic characterization of hypertrophic cardiomyopathy in human heart

W Wang, J Wang, K Yao, S Wang, M Nie… - Nature Cardiovascular …, 2022 - nature.com
Hypertrophic cardiomyopathy (HCM) is a common inherited cardiovascular disease with
heterogeneous clinical presentations, governed by multiple molecular mechanisms …

Novel therapies for prevention and early treatment of cardiomyopathies: now and in the future

GG Repetti, CN Toepfer, JG Seidman… - Circulation …, 2019 - Am Heart Assoc
Heritable cardiomyopathies are a class of heart diseases caused by variations in a number
of genetic loci. Genetic variants on one allele lead to either a degraded protein, which …